跳至主要内容
临床试验/NCT03239717
NCT03239717已完成不适用

The Metabolic Response to Reduced Branched-chain Amino Acids in Humans

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2017年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Reduction of BCAA intake

研究概览

简要总结

Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduction of dietary BCAAs will promote fat mass loss and improved control of blood glucose. The purpose of this study is to test if reduction of dietary BCAAs without reducing calorie intake will lead to similar metabolic benefits in humans. Here the investigators test the feasibility of reducing dietary BCAAs using BCAA-free meal replacement beverages for two months.

详细描述

This study, which will be completed over three months, involves replacing two meals a day with meal replacement beverages for two months, with a one month follow-up visit. These beverages will be made up by subjects using either a complete protein powder or BCAD2, a BCAA-free medical food. Participants will complete food diaries at baseline and at one month intervals during the study, and compliance will be assessed via food diaries, weekly telephone contact, and measuring returned food powder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male between the age of 35 - 65
  • BMI between 28 - 35 (mildly obese/overweight)
  • Fasting glucose level of 101 - 125 mg/dL
  • Able and willing to give written informed consent
  • Stable weight (within 5 lbs. for at least 3 months)
  • Not taking (or willing to cease taking) over the counter vitamin/mineral supplements
  • Not planning to begin an exercise or diet program

排除标准

  • Outside required age range of 35 - 65
  • BMI not within range of 28 - 35
  • Fasting glucose not within range of 101 - 125 mg/dL
  • Use of prescription medications for diabetes or weight-loss
  • Use of and unwillingness to discontinue over the counter supplements (e.g. cinnamon, chromium, protein powders) or weight loss beverage or meal plans (e.g. SlimFast or Jenny Craig).
  • Low baseline albumin or pre-albumin levels (below normal reference range)
  • Significant anemia (Hemoglobin < 11 g/dL)
  • Known bleeding disorder or platelet dysfunction
  • Already eating a low protein diet (less than 14% total caloric intake from protein), as calculated from food diaries provided by subjects
  • Participating in intensive exercise training program (high to moderate intensity exercise greater than 210 minutes per week) or planning to start new exercise program during study period.
  • Significant co-morbidities (including kidney disease, liver disease, GI disease, cardiovascular disease, respiratory disease, malnutrition, substance abuse, psychiatric disease, or a diagnosed eating disorder).
  • Planned smoking cessation or attempt at smoking cessation during study period
  • Inability to tolerate meal replacement beverages due to palatability
  • Recent weight loss (> 5 lbs within 3 months).
  • Bariatric surgery, gastric banding or liposuction
  • Current or past (within 1 year) use of illicit drugs
  • Claustrophobia

结局指标

主要结局

Reduction of BCAA intake

时间窗: 3 months

The principle outcome of this study is to determine if replacing 2/3rds of the subjects baseline protein intake with BCAA-free meal replacement beverages are a feasible method of selectively reducing BCAA consumption. Our principle outcome is to reduce BCAA intake by 50% or more in the Experimental Arm (BCAD2) of the study as compared to baseline intake.

次要结局

  • HbA1c(3 months)
  • Weight(3 months)
  • Fat mass(3 months)
  • BMI(3 months)
  • Resting metabolic rate(3 months)
  • Fasting blood glucose(3 months)
  • Insulin(3 months)
  • Glucose tolerance(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验